Propranolol inhibits molecular risk markers in HCT recipients: a phase 2 randomized controlled biomarker trial
| Autor: | Knight, Jennifer M. *, Rizzo, J. Douglas, Hari, Parameswaran, Pasquini, Marcelo C., Giles, Karen E., D'Souza, Anita, Logan, Brent R., Hamadani, Mehdi, Chhabra, Saurabh, Dhakal, Binod, Shah, Nirav, Sriram, Deepika, Horowitz, Mary M., Cole, Steve W. |
|---|---|
| Zdroj: | In Blood Advances 11 February 2020 4(3):467-476 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|